R-AXSPA

Clinical trials for R-AXSPA explained in plain language.

Never miss a new study

Get alerted when new R-AXSPA trials appear

Sign up with your email to follow new studies for R-AXSPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New drug aims to ease back pain and stiffness for arthritis patients

Symptom relief Not yet recruiting

This study tests whether the drug vilamakitug can reduce symptoms of axial spondyloarthritis, a type of arthritis that causes back pain and stiffness. About 150 adults with active disease will receive either the drug or a placebo. The main goal is to see if more people get at lea…

Matched conditions: R-AXSPA

Phase: PHASE2 • Sponsor: XBiotech, Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 12:33 UTC

R-AXSPA

Get alerted when new R-AXSPA trials appear

New drug aims to ease back pain and stiffness for arthritis patients